vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and BGSF, INC. (BGSF). Click either name above to swap in a different company.

ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $22.0M, roughly 1.0× BGSF, INC.). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs -9.4%). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs -5.3%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

BGSF Inc. is a leading U.S.-headquartered workforce solutions firm that provides tailored staffing, talent recruitment, and end-to-end workforce management services. It serves core segments including information technology, healthcare, professional administration, light industrial, and creative industries, catering to small, mid-sized and large enterprise clients across North America.

ADCT vs BGSF — Head-to-Head

Bigger by revenue
ADCT
ADCT
1.0× larger
ADCT
$23.1M
$22.0M
BGSF
Growing faster (revenue YoY)
ADCT
ADCT
+45.7% gap
ADCT
36.4%
-9.4%
BGSF
Faster 2-yr revenue CAGR
ADCT
ADCT
Annualised
ADCT
13.7%
-5.3%
BGSF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADCT
ADCT
BGSF
BGSF
Revenue
$23.1M
$22.0M
Net Profit
$-1.2M
Gross Margin
35.0%
Operating Margin
-77.7%
-17.6%
Net Margin
-5.3%
Revenue YoY
36.4%
-9.4%
Net Profit YoY
-18.2%
EPS (diluted)
$0.04
$-0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
BGSF
BGSF
Q4 25
$23.1M
$22.0M
Q3 25
$15.8M
$26.9M
Q2 25
$18.1M
$23.5M
Q1 25
$17.4M
$20.9M
Q4 24
$16.9M
$24.3M
Q3 24
$18.0M
$29.8M
Q2 24
$17.0M
$25.7M
Q1 24
$17.8M
$24.5M
Net Profit
ADCT
ADCT
BGSF
BGSF
Q4 25
$-1.2M
Q3 25
$-41.0M
$-5.8M
Q2 25
$-56.6M
$-3.7M
Q1 25
$-38.6M
$-722.0K
Q4 24
$-981.0K
Q3 24
$-44.0M
$-804.0K
Q2 24
$-36.5M
$-761.0K
Q1 24
$-46.6M
$-792.0K
Gross Margin
ADCT
ADCT
BGSF
BGSF
Q4 25
35.0%
Q3 25
35.9%
Q2 25
35.8%
Q1 25
36.2%
Q4 24
35.9%
Q3 24
35.9%
Q2 24
37.3%
Q1 24
38.1%
Operating Margin
ADCT
ADCT
BGSF
BGSF
Q4 25
-77.7%
-17.6%
Q3 25
-196.6%
-3.5%
Q2 25
-244.1%
-18.8%
Q1 25
-163.5%
1.6%
Q4 24
-191.8%
-15.7%
Q3 24
-197.4%
-3.4%
Q2 24
-170.5%
-5.7%
Q1 24
-188.3%
1.7%
Net Margin
ADCT
ADCT
BGSF
BGSF
Q4 25
-5.3%
Q3 25
-260.1%
-21.6%
Q2 25
-313.2%
-15.9%
Q1 25
-221.8%
-3.5%
Q4 24
-4.0%
Q3 24
-244.1%
-2.7%
Q2 24
-214.6%
-3.0%
Q1 24
-261.1%
-3.2%
EPS (diluted)
ADCT
ADCT
BGSF
BGSF
Q4 25
$0.04
$-0.12
Q3 25
$-0.30
$-0.52
Q2 25
$-0.50
$-0.34
Q1 25
$-0.36
$-0.06
Q4 24
$-0.26
Q3 24
$-0.42
$-0.07
Q2 24
$-0.38
$-0.07
Q1 24
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
BGSF
BGSF
Cash + ST InvestmentsLiquidity on hand
$261.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$48.1M
Total Assets
$323.1M
$57.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
BGSF
BGSF
Q4 25
$261.3M
Q3 25
$234.7M
$41.2M
Q2 25
$264.6M
$2.8M
Q1 25
$194.7M
$2.0M
Q4 24
$250.9M
$32.0K
Q3 24
$274.3M
$262
Q2 24
$300.1M
$226
Q1 24
$234.3M
$50
Stockholders' Equity
ADCT
ADCT
BGSF
BGSF
Q4 25
$-185.8M
$48.1M
Q3 25
$-238.2M
$50.7M
Q2 25
$-199.2M
$78.3M
Q1 25
$-238.2M
$81.8M
Q4 24
$-202.6M
$82.3M
Q3 24
$-171.9M
$82.9M
Q2 24
$-131.7M
$83.2M
Q1 24
$-194.4M
$83.6M
Total Assets
ADCT
ADCT
BGSF
BGSF
Q4 25
$323.1M
$57.8M
Q3 25
$289.8M
$83.6M
Q2 25
$321.6M
$149.7M
Q1 25
$272.5M
$152.3M
Q4 24
$322.0M
$150.1M
Q3 24
$349.1M
$157.3K
Q2 24
$371.8M
$159.8K
Q1 24
$308.0M
$170.6K

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
BGSF
BGSF
Operating Cash FlowLast quarter
$-31.1M
$1.7M
Free Cash FlowOCF − Capex
$1.7M
FCF MarginFCF / Revenue
7.6%
Capex IntensityCapex / Revenue
0.0%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-16.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
BGSF
BGSF
Q4 25
$-31.1M
$1.7M
Q3 25
$-29.6M
$-4.8M
Q2 25
$-24.1M
$2.2M
Q1 25
$-56.3M
$1.1M
Q4 24
$-21.9M
$3.2M
Q3 24
$-25.0M
$6.5M
Q2 24
$-32.8M
$7.3M
Q1 24
$-44.1M
$7.4M
Free Cash Flow
ADCT
ADCT
BGSF
BGSF
Q4 25
$1.7M
Q3 25
$-4.9M
Q2 25
$2.1M
Q1 25
$-56.6M
$1.0M
Q4 24
$-21.9M
$2.5M
Q3 24
$-25.3M
$6.5M
Q2 24
$-32.9M
$7.3M
Q1 24
$-44.6M
$6.9M
FCF Margin
ADCT
ADCT
BGSF
BGSF
Q4 25
7.6%
Q3 25
-18.1%
Q2 25
9.1%
Q1 25
-325.2%
5.0%
Q4 24
-129.8%
10.2%
Q3 24
-140.2%
21.7%
Q2 24
-193.0%
28.5%
Q1 24
-250.0%
28.1%
Capex Intensity
ADCT
ADCT
BGSF
BGSF
Q4 25
0.0%
0.1%
Q3 25
0.0%
0.4%
Q2 25
0.0%
0.0%
Q1 25
1.5%
0.1%
Q4 24
0.5%
3.0%
Q3 24
1.2%
0.0%
Q2 24
0.2%
0.0%
Q1 24
3.0%
2.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADCT
ADCT

Segment breakdown not available.

BGSF
BGSF

Contract Field Talent$21.4M97%
Other$595.0K3%

Related Comparisons